Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2672-2685

  Fisher, Bernard ^a   Bryant, John ^a   Wolmark, Norman ^a   Mamounas, Eleftherios ^a   Brown, Ann ^a   Fisher, Edwin R ^a   Wickerham, D Lawrence ^a   Begovic, Mirsada ^a   DeCillis, Arthur ^a   Robidoux, Andre ^a   Margolese, Richard G ^a   Cruz Jr , Anatolio B ^a   Hoehn, James L ^a   Lees, Alan W ^a   Dimitrov, Nikolay V ^a   Bear, Harry D ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

EID: 0031926839     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2672     Document Type: Article

References (20)

1. Gunduz N, Fisher B, Saffer EA: Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39:3861-3865, 1979
2. Fisher B, Gunduz N, Saffer EA: Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 43:1488-1492, 1983
3. Fisher B, Saffer EA, Rudock C, et al: Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 49:1996-2001, 1989
4. Fisher B, Saffer EA, Rudock C, et al: Effect of local or systemictreatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res 49:2002-2004, 1989
5. Goldie JH, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727-1733, 1979
6. Skipper HE: Kinetics of mammary tumor cell growth and implications for therapy. Cancer 28:1479-1499, 1971
7. Shick P, Goodstein J, Moor J, et al: Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer. J Surg Oncol 22:278-282, 1983
8. Sorace RA, Bagley CS, Lichter AS, et al: The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. World J Surg 9:775-785, 1985
9. Perloff M, Lesnick J: Chemotherapy before and after mastectomy in stage III breast cancer. Arch Surg 117:879-881, 1982
10. Jacquillat CI, Baillet F, Blondon J, et al: Preliminary results of neoadjuvant chemotherapy in initial management of breast cancer (BC). Proc Am Soc Clin Oncol 2:112, 1983 (abstr)
11. Fisher B, Brown A, Mamounas E, et al: The effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from NSABP B-18. J Clin Oncol 15:2483-2493, 1997
12. Fisher B, Wolmark N, Fisher ER, et al: Lumpectomy and axillary dissection for breast cancer: Surgical, pathological and radiation considerations. World J Surg 9:692-698, 1985
13. Mauriac L, Durand M, Avril A, et al: Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm: Results of a randomized trial in a single centre. Ann Oncol 2:347-354, 1991
14. Scholl SM, Fourquet A, Asselain B, et al: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur J Cancer 30A:645-652, 1994
15. Scholl SM, Pierga JY, Asselain B, et al: Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 31 A: 1969-1975, 1995
16. Van de Velde CJH: Preoperative chemotherapy in operable breast cancer: The influence of timing FEC in relation to surgery. Drugs 45:31-37, 1993 (suppl 2)
17. Powles TJ, Hickish TF, Makris A, et al: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13:547-552, 1995
18. Fisher B, Mamounas EP: Preoperative chemotherapy: A model for studying the biology and therapy of primary breast cancer, J Clin Oncol 13:537-540, 1995
19. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89:1673-1682, 1997
20. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med 320:479-484, 1989